Publication: Modulatory effects of phytoestrogens on the expression of Fas ligand and the release of cytochrome C in normal and cancerous endometrial cells
0
0
Issued Date
2012
Resource Type
File Type
application/pdf
ISSN
1252208
Other identifier(s)
2-s2.0-84876930108
Rights Holder(s)
มหาวิทยาลัยศรีนครินทรวิโรฒ
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol 95, No.SUPPL.12 (2012), p.S105-S112
Suggested Citation
Poonyachoti S., Deachapunya C. Modulatory effects of phytoestrogens on the expression of Fas ligand and the release of cytochrome C in normal and cancerous endometrial cells. Journal of the Medical Association of Thailand. Vol 95, No.SUPPL.12 (2012), p.S105-S112. Retrieved from: https://hdl.handle.net/20.500.14740/6905
Author(s)
Abstract
Cytochrome c (CytC) released from mitochondria induces apoptosis in both normal and tumor cells. Expression of Fas ligand (FasL) helps maintain tumor cell survival by inducing apoptosis of Fas-bearing anti-tumor immune cells. A risk of endometrial cancer has been reported to associate with phytoestrogen consumption. Therefore the effects of phytoestrogens, genistein and daidzein, on FasL and CytC protein expression were examined in primary cultured porcine endometrial cells (PE) and human cancerous endometrial cells (RL95-2) by Western blot analysis. Both cells were cultured in standard medium (SM) and switched to estrogen-deprived medium (SF) with or without 17β-estradiol (E, 1 nM), genistein (10 μM) or daidzein (10 μM) for 48 h. FasL (25 kDa) which was found only in RL95-2 cells was upregulated in SF compared to SM. Treatment of RL95-2 cells with E, daidzein or genistein significantly increased the FasL expression by 7-10 folds. In the present study, low level of CytC was detected in both cells cultured in SM but markedly increased in SF by 1.5-2 folds. The SF-induced increase in CytC level was reversed by genistein or daidzein while E suppressed CytC in PE cells, but not in RL95-2 cells. The findings suggest that genistein and daidzein appear to act as a survival factor by inhibiting intracellular apoptogenic initiator in both normal and cancer endometrial cells. In addition, estrogen and phytoestrogens inducing the death signal FasL expressed by cancerous endometrial cells may cause the tumor progression. Thus, consuming phytoestrogen as a supplement should be awareness in patient with endometrial cancer.
Subject(s)
Cytochrome c
Daidzein
Estradiol
Estrogen
Fas ligand
Genistein
Insulin
Phytoestrogen
Animal cell
Apoptosis
Article
Controlled study
Densitometry
Endometrium cancer
Human
Human cell
Nonhuman
Protein expression
Swine
Upregulation
Western blotting
Analysis of Variance
Animals
Apoptosis
Blotting, Western
Cells, Cultured
Cytochromes c
Endometrial Neoplasms
Estradiol
Fas Ligand Protein
Female
Genistein
Humans
Isoflavones
Phytoestrogens
Swine
Daidzein
Estradiol
Estrogen
Fas ligand
Genistein
Insulin
Phytoestrogen
Animal cell
Apoptosis
Article
Controlled study
Densitometry
Endometrium cancer
Human
Human cell
Nonhuman
Protein expression
Swine
Upregulation
Western blotting
Analysis of Variance
Animals
Apoptosis
Blotting, Western
Cells, Cultured
Cytochromes c
Endometrial Neoplasms
Estradiol
Fas Ligand Protein
Female
Genistein
Humans
Isoflavones
Phytoestrogens
Swine
